These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19130039)

  • 1. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study.
    Barr EL; Boyko EJ; Zimmet PZ; Wolfe R; Tonkin AM; Shaw JE
    Diabetologia; 2009 Mar; 52(3):415-24. PubMed ID: 19130039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study.
    Barr EL; Cameron AJ; Balkau B; Zimmet PZ; Welborn TA; Tonkin AM; Shaw JE
    Diabetologia; 2010 Jan; 53(1):79-88. PubMed ID: 19894029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of dyslipidaemia on cardiovascular mortality in individuals without a prior history of diabetes in the DECODE Study.
    Zhang L; Qiao Q; Tuomilehto J; Hammar N; Ruotolo G; Stehouwer CD; Heine RJ; Eliasson M; Zethelius B;
    Atherosclerosis; 2009 Sep; 206(1):298-302. PubMed ID: 19303072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?
    DECODE Study Group, European Diabetes Epidemiology Group
    Diabetes Care; 2003 Mar; 26(3):688-96. PubMed ID: 12610023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes - a 10-year follow-up: Tehran Lipid and Glucose Study.
    Afsharian S; Akbarpour S; Abdi H; Sheikholeslami F; Moeini AS; Khalili D; Momenan AA; Azizi F; Hadaegh F
    Diabetes Metab Res Rev; 2016 Sep; 32(6):596-606. PubMed ID: 26787367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study.
    Meigs JB; Nathan DM; D'Agostino RB; Wilson PW;
    Diabetes Care; 2002 Oct; 25(10):1845-50. PubMed ID: 12351489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus.
    Schöttker B; Müller H; Rothenbacher D; Brenner H
    Diabetologia; 2013 Jan; 56(1):92-100. PubMed ID: 22986731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
    Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
    Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study.
    Eskesen K; Jensen MT; Galatius S; Vestergaard H; Hildebrandt P; Marott JL; Jensen JS
    J Intern Med; 2013 Jan; 273(1):94-101. PubMed ID: 23009556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
    Jesudason DR; Dunstan K; Leong D; Wittert GA
    Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
    Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
    Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).
    Valdés S; Botas P; Delgado E; Alvarez F; Díaz-Cadórniga F
    Diabetes Metab; 2011 Feb; 37(1):27-32. PubMed ID: 20934897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk).
    Khaw KT; Wareham N; Luben R; Bingham S; Oakes S; Welch A; Day N
    BMJ; 2001 Jan; 322(7277):15-8. PubMed ID: 11141143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The joint association of physical activity and glycaemic control in predicting cardiovascular death and all-cause mortality in the US population.
    Reddigan JI; Riddell MC; Kuk JL
    Diabetologia; 2012 Mar; 55(3):632-5. PubMed ID: 22080254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study.
    Faerch K; Borch-Johnsen K; Vaag A; Jørgensen T; Witte DR
    Diabetologia; 2010 May; 53(5):858-65. PubMed ID: 20182862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin.
    Nakagami T;
    Diabetologia; 2004 Mar; 47(3):385-394. PubMed ID: 14985967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of time of day and fasting duration on measures of glycaemia: analysis from the Whitehall II Study.
    Hulmán A; Færch K; Vistisen D; Karsai J; Nyári TA; Tabák AG; Brunner EJ; Kivimäki M; Witte DR
    Diabetologia; 2013 Feb; 56(2):294-7. PubMed ID: 23143165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.